Tech Company Financing Transactions

Apse Funding Round

Apse, based in St. Louis, secured $667.1 thousand from private investors.

Transaction Overview

Company Name
Announced On
10/30/2013
Transaction Type
Debt
Venture Equity
Amount
$667,139
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4320 Forest Park Ave. 303
St. Louis, MO 63108
USA
Email Address
Not Recorded
Overview
Apse is a biotechnology company seeking to commercialize a portfolio of Novel Nanomaterials. We have identified five application areas of immediate, developing, and future needs addressed by technology we invented for which we have several U.S. Patents Pending. This strategy enables a robust financing path for growth.
Profile
Apse LinkedIn Company Profile
Social Media
Apse Company Twitter Account
Company News
Apse News
Facebook
Apse on Facebook
YouTube
Apse on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
John Killmer
  John Killmer LinkedIn Profile  John Killmer Twitter Account  John Killmer News  John Killmer on Facebook
Chief Scientific Officer
Juan Arhancet
  Juan Arhancet LinkedIn Profile  Juan Arhancet Twitter Account  Juan Arhancet News  Juan Arhancet on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/30/2013: PathoGenetix venture capital transaction
Next: 10/30/2013: Breakthrough Products venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary